DOP054: Vedolizumab in combination with steroids for induction therapy in Crohn’s Disease: An exploratory analysis of the GEMINI 2 and GEMINI 3 studiesECCO'18 Vienna 2018
1
DOP055: Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active Ulcerative Colitis patientsECCO'18 Vienna 2018
1
DOP058: Combined stem cells and anticytokine therapy contributes to a more pronounced decrease in the degree of inflammation of the intestinal mucosa in Crohn's DiseaseECCO'18 Vienna 2018
1
DOP059: Combined anticytokine and local mesenchymal stem cells therapy promotes longer healing of simple fistulas in patients with Crohn's DiseaseECCO'18 Vienna 2018
1
DOP061: Human amnion epithelial cells reduce intestinal inflammation in a 2,4,6-trinitrobenzene sulfonic acid induced model of Acute ColitisECCO'18 Vienna 2018
1
DOP062: The anti-MAdCAM antibody SHP647 in Crohn’s Disease: Endoscopic effects of induction therapyECCO'18 Vienna 2018
1
DOP064: ECCO expert consensus and topical review on treatment exit strategies in Inflammatory Bowel DiseaseECCO'18 Vienna 2018
1
DOP065: Long term cost effectiveness of tight control for Crohn’s Disease with adalimumab-based treatment: Economic evaluation beyond 48 weeks of CALM trialECCO'18 Vienna 2018
1
DOP068: Crohn’s Disease decision aid leads to more patients choosing combination therapy in a cluster randomised controlled trialECCO'18 Vienna 2018
1
DOP069: Improved quality of care quality of life for IBD patients using mobile based remote monitoring platform: A randomised control trialECCO'18 Vienna 2018
1
DOP070: Development and pilot of an index to identify young people with Inflammatory Bowel Disease at risk of psychological morbidityECCO'18 Vienna 2018
1
DOP071: Tight control with adalimumab-based treatment is associated with improved quality of life outcomes in patients with moderate to severely active Crohn's Disease: Data from CALMECCO'18 Vienna 2018
1
DOP072: Achieving biochemical remission with adalimumab therapy using therapeutic drug monitoring: Results of a large prospective Crohn’s Disease cohortECCO'18 Vienna 2018
1
DOP074: IL-33 promotes gut mucosal wound healing by inducing miRNA-320 to stimulate epithelial restitution and repairECCO'18 Vienna 2018
1